Seminars in Radiation Oncology
Volume 22, Issue 1 , Pages 11-17 , January 2012

A Clinical Approach to Technology Assessment: How Do We and How Should We Choose the Right Treatment?

  • Anthony Zietman, MD

      Affiliations

    • Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA
    • Corresponding Author InformationAddress reprint requests to Anthony Zietman, MD, Department of Radiation Oncology, Massachusetts General Hospital, Fruit Street, Boston, MA 02114
    • ,
  • Geoffrey Ibbott, PhD

      Affiliations

    • M.D. Anderson Cancer Center, Houston, TX

References 

  1. http://www.fda.gov Accessed May 10, 2011
  2. Emanuel Z , Fuks VR . The perfect storm of over-utilization . JAMA . 2008;299:2789–2791
  3. Technopoly PN . The Surrender of Culture to Technology . New York, NY: Vintage Books, Random House, Inc; 1993;
  4. Dearnaley DP , Khoo VS , Norman AR , et al.  Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: A randomized trial . Lancet . 1999;353:267–272
  5. Rawlins M . De testimonio: On the evidence for decisions about the use of therapeutic interventions . Lancet . 2008;372:2152–2161
  6. Shah BR , Drozda J , Peterson ED . Leveraging observational registries to inform comparative effectiveness research . Am Heart J . 2010;160:8–15
  7. Nugent WC , Nugent WC , Ross CS , et al.  Building and supporting sustainable improvement in cardiac surgery: The Northern New England experience . Semin Cardiothorac Vasc Anesth . 2005;9:119–121
  8. Talcott JA , Rossi C , Shipley WU , et al.  Patient-reported outcomes after conventional and high-dose combined proton and photon radiation for early prostate cancer (PROG 9509): Long-term results from a randomized trial . JAMA . 2010;303:1046–1053
  9. Makarov DV , Yu JB , Desai RA , et al.  The association between diffusion of the surgical robot and radical prostatectomy rates . Med Care . 2011;49:333–339
  10. Hu JC , Gu X , Lipsitz SR , et al.  Comparative effectiveness of minimally invasive vs open radical prostatectomy . JAMA . 2009;302:1557–1564
  11. Shepard DS , Weinstein MC . Utility functions for life years and health status . Oper Res . 1980;28:206–224
  12. Cleemput I , Neyt M , Thiry N , et al.  Using threshold values for cost per quality-adjusted life-year gained in healthcare decisions . Int J Technol Assess Health Care . 2011;27:71–76
  13. http://www.icer-review.org Accessed May 10, 2011
  14. Bentzen S , Ritter MA . The alpha/beta ratio for prostate cancer: What is it really? . Radiother Oncol . 2005;76:1–3
  15. Dale RG , Carabe-Fernandez A , Cárabe-Fernández A . Why more needs to be known about RBE effects in modern radiotherapy . Appl Radiat Isot . 2009;67:387–392
  16. rann A , Grann VR , Daniels S , et al.  The case for randomized trials in cancer treatment: New is not always better . JAMA . 2005;293:970–978
  17. Joensuu H , Roberts BJ , Sarlomo-Rikala M , et al.  Effect of the tyrosine kinase inhibitor ST1571 in a patient with a metastatic gastrointestinal stromal tumor . N Engl J Med . 2001;344:1052–1056
  18. Zietman A , Tepper J , Goitein M . Technology evolution: Is it survival of the fittest? . J Clin Oncol . 2010;28:4275–4279

PII: S1053-4296(11)00099-3

doi: 10.1016/j.semradonc.2011.09.008

Seminars in Radiation Oncology
Volume 22, Issue 1 , Pages 11-17 , January 2012

Article Tools